Stocktoria
Medtronic plc MDT
NYSE · XNYS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1977-11-21
Medtronic plc financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $36.4B | $33.5B | $32.4B | $31.2B | $31.7B |
| SG&A expense | $11.8B | $10.8B | $10.7B | $10.4B | $10.3B |
| Operating income | $6.5B | $6.0B | $5.1B | $5.5B | $5.8B |
| Interest expense | — | — | $719.0M | $636.0M | $553.0M |
| Income tax | $1.3B | $936.0M | $1.1B | $1.6B | $456.0M |
| Net income | $4.8B | $4.7B | $3.7B | $3.8B | $5.0B |
| EPS (diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 |
| Operating cash flow | $7.3B | $7.0B | $6.8B | $6.0B | $7.3B |
| Free cash flow | $5.4B | $5.2B | $5.2B | $4.6B | $6.0B |
| Cash & equivalents | $1.9B | $2.2B | $1.3B | $1.5B | $3.7B |
| Inventory | $6.0B | $5.5B | $5.2B | $5.3B | $4.6B |
| Total assets | $93.0B | $91.7B | $90.0B | $90.9B | $91.0B |
| Total liabilities | $43.0B | $43.4B | $39.6B | $39.3B | $38.3B |
| Shareholders' equity | $50.1B | $48.3B | $50.4B | $51.7B | $52.7B |
Source: SEC EDGAR filings · CIK 0001613103 · as of 2026-04-24. Facts from filings plus Stocktoria's own computed scores — not investment advice.